CARMELL CORP (CTCX) Stock Price, Forecast & Analysis
USA - NASDAQ:CTCX - US1429221039 - Common Stock
CTCX Key Statistics, Chart & Performance
The current stock price of CTCX is 0.1973 USD. In the past month the price decreased by -41.64%. In the past year, price decreased by -93.31%.
CTCX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 23.19 | 387.16B | ||
| AMGN | AMGEN INC | 14.64 | 172.38B | ||
| GILD | GILEAD SCIENCES INC | 14.51 | 147.46B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.59 | 104.98B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.61 | 69.69B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 868.04 | 58.03B | ||
| INSM | INSMED INC | N/A | 40.10B | ||
| NTRA | NATERA INC | N/A | 27.39B | ||
| BIIB | BIOGEN INC | 9.29 | 22.80B | ||
| INCY | INCYTE CORP | 16.51 | 20.70B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.01 | 20.30B | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 36.45 | 15.11B |
Related stock screener links
About CTCX
Company Profile
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasmabased bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 9 full-time employees. The company went IPO on 2021-07-29. The firm utilizes the Carmell Secretome to support skin and hair health. The Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from United States Food and Drug Administration-approved tissue banks. The firm has developed a novel micellar nanoparticle formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the harmful excipients that are used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. Additionally, Carmell’s micellar formulations do not utilize mineral or vegetable oils across their entire product line and are designed to be non-comedogenic. The firm is also developing a line of men’s products and a line of topical haircare products.
Company Info
CARMELL CORP
2403 Sidney Street, Suite 300
Pittsburgh PENNSYLVANIA US
Employees: 9
Phone: 14128948248
CARMELL CORP / CTCX FAQ
Can you describe the business of CARMELL CORP?
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasmabased bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 9 full-time employees. The company went IPO on 2021-07-29. The firm utilizes the Carmell Secretome to support skin and hair health. The Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from United States Food and Drug Administration-approved tissue banks. The firm has developed a novel micellar nanoparticle formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the harmful excipients that are used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. Additionally, Carmell’s micellar formulations do not utilize mineral or vegetable oils across their entire product line and are designed to be non-comedogenic. The firm is also developing a line of men’s products and a line of topical haircare products.
Can you provide the latest stock price for CARMELL CORP?
The current stock price of CTCX is 0.1973 USD. The price increased by 1.39% in the last trading session.
Does CARMELL CORP pay dividends?
CTCX does not pay a dividend.
What is the ChartMill rating of CARMELL CORP stock?
CTCX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the GICS sector and industry of CTCX stock?
CARMELL CORP (CTCX) operates in the Health Care sector and the Biotechnology industry.
How many employees does CARMELL CORP have?
CARMELL CORP (CTCX) currently has 9 employees.
Can you provide the ownership details for CTCX stock?
You can find the ownership structure of CARMELL CORP (CTCX) on the Ownership tab.
CTCX Technical Analysis
CTCX Financial Highlights
Over the last trailing twelve months CTCX reported a non-GAAP Earnings per Share(EPS) of -1.91. The EPS decreased by -335.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1047.34% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |